These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 35198435)

  • 1. Contribution of Epithelial and Gut Microbiome Inflammatory Biomarkers to the Improvement of Colorectal Cancer Patients' Stratification.
    Ionica E; Gaina G; Tica M; Chifiriuc MC; Gradisteanu-Pircalabioru G
    Front Oncol; 2021; 11():811486. PubMed ID: 35198435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response.
    Sánchez-Alcoholado L; Ramos-Molina B; Otero A; Laborda-Illanes A; Ordóñez R; Medina JA; Gómez-Millán J; Queipo-Ortuño MI
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Role of Gut Microbiome in Colon Cancer.
    Chattopadhyay I; Dhar R; Pethusamy K; Seethy A; Srivastava T; Sah R; Sharma J; Karmakar S
    Appl Biochem Biotechnol; 2021 Jun; 193(6):1780-1799. PubMed ID: 33492552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
    Avuthu N; Guda C
    Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of gut microbes and its metabolites in colorectal cancer.
    Kumar A; Ali A; Kapardar RK; Dar GM; Nimisha ; Apurva ; Sharma AK; Verma R; Sattar RSA; Ahmad E; Mahajan B; Saluja SS
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):441-465. PubMed ID: 36572792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer.
    Ahmad Kendong SM; Raja Ali RA; Nawawi KNM; Ahmad HF; Mokhtar NM
    Front Cell Infect Microbiol; 2021; 11():744606. PubMed ID: 34966694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
    Hou H; Chen D; Zhang K; Zhang W; Liu T; Wang S; Dai X; Wang B; Zhong W; Cao H
    Cancer Lett; 2022 Feb; 526():225-235. PubMed ID: 34843863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy.
    Gomes S; Rodrigues AC; Pazienza V; Preto A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiome in tumorigenesis and therapy of colorectal cancer.
    Wang L; Yu KC; Hou YQ; Guo M; Yao F; Chen ZX
    J Cell Physiol; 2023 Jan; 238(1):94-108. PubMed ID: 36409765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing Colorectal Cancer through Prebiotics.
    Mahdavi M; Laforest-Lapointe I; Massé E
    Microorganisms; 2021 Jun; 9(6):. PubMed ID: 34207094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships of Gut Microbiota Composition, Short-Chain Fatty Acids and Polyamines with the Pathological Response to Neoadjuvant Radiochemotherapy in Colorectal Cancer Patients.
    Sánchez-Alcoholado L; Laborda-Illanes A; Otero A; Ordóñez R; González-González A; Plaza-Andrades I; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment.
    Liu Y; Lau HC; Cheng WY; Yu J
    Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):84-96. PubMed ID: 35914737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the microbiome with colorectal cancer development (Review).
    Abdulla MH; Agarwal D; Singh JK; Traiki TB; Pandey MK; Ahmad R; Srivastava SK
    Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota in colorectal cancer development and therapy.
    Wong CC; Yu J
    Nat Rev Clin Oncol; 2023 Jul; 20(7):429-452. PubMed ID: 37169888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysbiosis of gut microbiota in promoting the development of colorectal cancer.
    Zou S; Fang L; Lee MH
    Gastroenterol Rep (Oxf); 2018 Feb; 6(1):1-12. PubMed ID: 29479437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
    John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
    J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of the Gut Microbiome in Colorectal Cancer.
    Chen GY
    Clin Colon Rectal Surg; 2018 May; 31(3):192-198. PubMed ID: 29720905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects.
    Li J; Zhang AH; Wu FF; Wang XJ
    Front Oncol; 2022; 12():841552. PubMed ID: 35223525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the Gut Microbiome and Fecal Metabolome in Colorectal Cancer: Implication of Intestinal Metabolism for Tumorigenesis.
    Du X; Li Q; Tang Z; Yan L; Zhang L; Zheng Q; Zeng X; Chen G; Yue H; Li J; Zhao M; Han YP; Fu X
    Front Physiol; 2022; 13():854545. PubMed ID: 35600308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.